Product NDC: | 59630-659 |
Proprietary Name: | Kapvay |
Non Proprietary Name: | clonidine hydrochloride |
Active Ingredient(s): | .2 mg/1 & nbsp; clonidine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59630-659 |
Labeler Name: | Shionogi Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022331 |
Marketing Category: | NDA |
Start Marketing Date: | 20101209 |
Package NDC: | 59630-659-60 |
Package Description: | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (59630-659-60) |
NDC Code | 59630-659-60 |
Proprietary Name | Kapvay |
Package Description | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (59630-659-60) |
Product NDC | 59630-659 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clonidine hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20101209 |
Marketing Category Name | NDA |
Labeler Name | Shionogi Inc. |
Substance Name | CLONIDINE HYDROCHLORIDE |
Strength Number | .2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |